| 1 | 1-(3-乙酰基-1-双环[1.1.1]戊烷基)已酮 | 1-(3-Acetyl-1-Bicyclo[1.1.1]Pentanyl)Ethanone | 115913-30-9 | 中间体-医药中间体 | |
| 2 | 1,3-双环[1.1.1]戊烷二甲酸 | 1,3-Bicyclo[1.1.1]pentanedicarboxylic acid | 56842-95-6 | 中间体-医药中间体 | |
| 3 | 双环[1.1.1]戊烷-1,3-二甲酸单甲酯 | Bicyclo[1.1.1]pentane-1,3-dicarboxylic acid monomethyl ester | 83249-10-9 | 中间体-医药中间体 | |
| 4 | 双环[1.1.1]戊烷-1,3-二甲酸二甲酯 | Bicyclo[1.1.1]pentane-1,3-dicarboxylic acid dimethyl ester | 115913-32-1 | 中间体-医药中间体 | |
| 5 | N-Boc-3-羟基氮杂环丁烷 | 1-N-Boc-3-hydroxyazetidine | 141699-55-0 | 中间体- | |
| 6 | 1-Boc-3-氮杂环丁酮 | 1-Boc-3-azetidinone | 398489-26-4 | 中间体- | |
| 7 | 3-羟基氮杂环丁烷盐酸盐 | 3-Hydroxyazetidine hydrochloride | 18621-18-6 | 中间体- | |
| 8 | 3-氰基吖丁啶盐酸盐 | 3-Cyanoazetidine hydrochloride | 345954-83-8 | 中间体- | |
| 9 | 叔-丁基3-亚甲基吖丁啶-1-羧酸酯 | Tert-butyl 3-methyleneazetidine-1-carboxylate | 934664-41-2 | 中间体- | |
| 10 | N-二苯甲基氮杂环丁烷-3-醇 | 1-(Diphenylmethyl)-3-hydroxyazetidine | 18621-17-5 | 中间体- | |
| 11 | 1-二苯甲基-3-氰基氮杂环丁烷 | 1-Benzhydrylazetane-3-carbonitrile | 36476-86-5 | 中间体- | |
| 12 | N-Boc-4-亚甲基哌啶 | 1-Boc-4-methylenepiperidine | 159635-49-1 | 中间体- | |
| 13 | 环丙基硼酸 | Cyclopropylboronic acid | 411235-57-9 | 中间体- | |
| 14 | 1-苄基-3-氧代哌啶-4-甲酸乙酯 | Ethyl 1-benzyl-3-oxopiperidine-4-carboxylate | 39514-19-7 | 中间体- | |
| 15 | 1-苄基-4-哌啶酮-3-羧酸乙酯 | 1-Benzyl-3-ethoxycarbonyl-4-piperidone | 41276-30-6 | 中间体- | |
| 16 | 肼基甲酸叔丁酯 | tert-Butyl carbazate | 870-46-2 | 中间体- | |
| 17 | (四氢-2H-吡喃-4-基)肼 | (Tetrahydro-2H-pyran-4-yl)hydrazine | 116312-69-7 | 中间体-医药中间体 | |
| 18 | 环丙甲肼 | (Cyclopropylmethyl)hydrazine | 40487-93-2 | 中间体-医药中间体 | |
| 19 | 戴斯-马丁氧化剂 | Dess-Martin periodinane | 87413-09-0 | 中间体- | |
| 20 | (甲氧基甲基)三苯基鏻溴化物 | (Methoxymethyl)Triphenylphosphonium Bromide | 33670-32-5 | 中间体-医药中间体 | |
| 21 | 喹啉-2-甲醛 | 2-Quinolinecarboxaldehyde | 5470-96-2 | 中间体- | |
| 22 | [(吗啉-2-基)甲基]氨基甲酸叔丁酯 | tert-Butyl [(morpholin-2-yl)methyl]carbamate | 173341-02-1 | 中间体- | |
| 23 | 1-氨基环丁烷羧酸 | 1-Aminocyclobutanecarboxylic Acid | 22264-16-0 | 中间体- | |
| 24 | (氯氨基)甲基亚基-二氨基甲酸二甲酯 | Dimethyl [(chloroamino)methylylidene]biscarbamate | 1596379-00-8 | 中间体-医药中间体 | |
| 25 | 2-[(氨基氧基)磺酰]-1,3,5-三甲基苯 | O-Mesitylenesulfonylhydroxylamine | 36016-40-7 | 中间体- | |
| 26 | N-(甲氧甲基)-N-(三甲基硅甲基)苄胺 | N-(Methoxymethyl)-N-(trimethylsilylmethyl)benzylamine | 93102-05-7 | 中间体- | |
| 27 | O-(4-硝基苯甲酰基)羟胺 | O-(4-Nitrobenzoyl)hydroxylamine | 35657-36-4 | 中间体- | |
| 28 | 3-氯甲基-1,2,4-三唑啉-5-酮 | 3-Chloromethyl-1,2,4-triazolin-5-one | 252742-72-6 | 中间体- | |
| 29 | (1S,3S,6R)-N,N-二甲基-7-氧杂双环〔4.1.0〕庚烷-3-甲酰胺 | (1S,3S,6R)-N,N-Dimethyl-7-oxabicyclo[4.1.0]heptane-3-carboxamide | 929693-35-6 | 中间体-医药中间体 | |
| 30 | 2-溴-6-氟苯甲醛 | 2-Bromo-6-fluorobenzaldehyde | 360575-28-6 | 中间体- | |
| 31 | 4-溴苯并[b]噻吩 | 4-Bromobenzo[b]thiophene | 5118-13-8 | 中间体- | |
| 32 | 6-(叔丁氧羰基)-3,6-二氮杂双环[3.1.1]庚烷 | 6-(tert-Butyloxycarbonyl)-3,6-diazabicyclo[3.1.1]heptane | 869494-16-6 | 中间体-医药中间体 | |
| 33 | 沃拉帕莎 | Vorapaxar | 618385-01-6 | 中间体- | |
| 34 | 富马酸沃诺拉赞 | Vonoprazan Fumarate | 881681-01-2 | 中间体-医药中间体 | |
| 35 | 维达列汀 | Vildagliptin | 274901-16-5 | 中间体- | |
| 36 | 维替泊芬 | Verteporfin | 129497-78-5 | 中间体- | |
| 37 | 维帕他韦 | Velpatasvir | 1377049-84-7 | 中间体-医药中间体 | |
| 38 | 托格列净一水合物(1:1) | Tofogliflozin | 1201913-82-7 | 中间体- | |
| 39 | 托法替尼 | Tofacitinib BASE | 477600-75-2 | 中间体- | |
| 40 | 枸橼酸托法替尼 | Tofacitinib Citratet | 540737-29-9 | 中间体- | |
| 41 | 曲格列汀 | Trelagliptin | 865759-25-7 | 中间体-医药中间体 | |
| 42 | 曲格列汀琥珀酸盐 | Trelagliptin succinate | 1029877-94-8 | 中间体- | |
| 43 | 曲氟胸苷 | Trifluridine | 70-00-8 | 中间体- | |
| 44 | 替卡格雷 | Ticagrelor | 274693-27-5 | 中间体- | |
| 45 | 特力利汀 | Teneligliptin | 760937-92-6 | 中间体- | |
| 46 | 特力利汀氢溴酸盐 | Teneligliptin Hydrobromide | 906093-29-6 | 中间体-医药中间体 | |
| 47 | 特力利汀氢溴酸盐一水合物 | Teneligliptin sesquihydrobromide hydrate | 1572583-29-9 | 中间体-医药中间体 | |
| 48 | 特地唑胺 | Tedizolid | 856866-72-3 | 中间体- | |
| 49 | 磷酸特地唑胺 | Tedizolid phosphate | 856867-55-5 | 中间体-医药中间体 | |
| 50 | 索非布韦 | Sofosbubir | 1190307-88-0 | 中间体- | |